Anti-PD-1 therapy linked to delayed onset of skin disease
The onset of side effects of a common cancer treatment, anti-PD-1 therapy can be identified up to 3 years after treatment...
List view / Grid view
The onset of side effects of a common cancer treatment, anti-PD-1 therapy can be identified up to 3 years after treatment...
The EU and Japan have agreed to widen the range of medicines for which they will recognise each other’s inspections of manufacturing sites.
ProCellics™, first in-line and real-time bioprocess raman analyser, is a RESOLUTION Spectra Systems product. It offers a GMP user-friendly and easily deployed Process Analytical Technology (PAT) solution...
Decagon, a new artificial intelligence (AI) system, may be able to predict side effects of different drug combinations in patients, making it easier for doctors to prescribe variations of treatments...
A novel drug based on capsaicin caused long-term weight loss and improved metabolic health in mice eating a high-fat diet...
The US Food and Drug Administration has approved TPOXX (tecovirimat), the first drug with an indication for treatment of smallpox...
Results of a study suggest the need for caution in the prescription of direct oral anticoagulants for patients with chronic kidney disease, due to the risk of bleeding...
A trade deal between the UK and USA could risk increasing drug prices in the UK, which could diminish the affordability and accessibility of the NHS...
The global biotechnology services outsourcing market is expected to reach USD 92.9 billion by 2025, according to a report by Grand View Research, Inc...
The global clinical microbiology market is projected to reach USD 4.95bn by 2023 from USD 3.63bn in 2018, growing at a CAGR of 6.4% from 2018 to 2023.
Peak Scientific, the global leader in gas generation for analytical laboratories, has today introduced a new nitrogen gas solution to the market, Genius SQ 24...
Watson for Clinical Trial Matching, an AI platform, has shown an increase of 80 percent in enrolment for breast cancer clinical trials, along with reduced screening times for patients...
Algenuity, based in Stewartby, Bedfordshire, is celebrating the successful launch of the MicroalgaE as Renewable Innovative green cell facTories project, MERIT, a three-year ERA CoBioTech project financed under the Horizon 2020 programme...
Two companies will work closely together on future development, distribution, promotion, access, marketing and sales of Invokana (canagliflozin) for type 2 diabetes...
Scientists are conducting a joint study to develop a radioactive marker, based on nanoparticles, for the detection of cancer...